Late Recurrence of Metastatic Meningioma in the Lung in a Patient with Endometrial Cancer: A Case Report

被引:2
作者
Alshibany, Aisha Mohammed [1 ]
Al-Husaini, Hamed Homoud [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Oncol Ctr, Dept Med Oncol, Riyadh, Saudi Arabia
关键词
Carcinoma; Endometrioid; Meningioma; Neoplasm Metastasis; PHASE-II TRIAL; RADIATION; SURGERY; THERAPY; TUMORS;
D O I
10.12659/AJCR.930708
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Unusual clinical course Background: Meningiomas are the most frequently diagnosed of all primary brain tumors, including glioblastomas, and of all other central nervous system tumors. While non-malignant meningiomas account for 36.7% of all primary brain tumors, malignant meningioma is much less common, accounting for just 0.6%. The annual incidence of meningiomas in the United States is 5.3 per 100 000 people. The median age of diagnosis is 64, and incidence rises steadily with advancing age. Furthermore, extracranial metastatic meningioma remains extremely rare (0.1%), with the most common location for metastasis being the lung. Case Report: We report a case of a patient with biopsy-proven endometrial adenocarcinoma with suspicious lung nodule, Stage IVB. She was managed with chemotherapy followed by surgery and radiation. During her course of management, she was found to have progressive pulmonary nodules. Later, biopsy from the pulmonary nodules showed a metastatic meningioma. Conclusions: Our case highlights the importance of early recognition of metastatic meningioma, especially when treating patients with a history of intracranial meningioma.
引用
收藏
页数:6
相关论文
共 23 条
  • [1] Black PM, 2008, NEUROSURGERY, V62, P1115, DOI [10.1227/01.NEU.0000318093.43855.2A, 10.1227/01.neu.0000333778.66316.38]
  • [2] SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
    Bruns, C
    Lewis, I
    Briner, U
    Meno-Tetang, G
    Weckbecker, G
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (05) : 707 - 716
  • [3] Recurrent meningioma - Salvage therapy with long-acting somatostatin analogue
    Chamberlain, Marc C.
    Glantz, Michael J.
    Fadul, Camilo E.
    [J]. NEUROLOGY, 2007, 69 (10) : 969 - 973
  • [4] Adjuvant combined modality therapy for malignant meningiomas
    Chamberlain, MC
    [J]. JOURNAL OF NEUROSURGERY, 1996, 84 (05) : 733 - 736
  • [5] Coexistence of Intracranial Meningioma, Pulmonary Meningiomas, and Lung Cancer
    Cheng, Yu-Jen
    Wu, Jiun-Ting
    Chen, Huei-Yong
    Wang, Kang-Hung
    Tsai, Jen-Wei
    Liliang, Po-Chou
    Chang, Po-Chih
    [J]. ANNALS OF THORACIC SURGERY, 2011, 91 (04) : 1283 - 1285
  • [6] Greene S, 2014, ENCY NEUROLOGICAL SC, V2nd
  • [7] Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes
    Islim, Abdurrahman I.
    Mohan, Midhun
    Moon, Richard D. C.
    Srikandarajah, Nisaharan
    Mills, Samantha J.
    Brodbelt, Andrew R.
    Jenkinson, Michael D.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (02) : 211 - 221
  • [8] Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005
    Ji, Yongli
    Rankin, Cathryn
    Grunberg, Steven
    Sherrod, Andy E.
    Ahmadi, Jamshid
    Townsend, Jeannette J.
    Feun, Lynn G.
    Fredericks, Ruth K.
    Russell, Christy A.
    Kabbinavar, Fairooz F.
    Stelzer, Keith J.
    Schott, Anne
    Verschraegen, Claire
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) : 4093 - +
  • [9] Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
    Kaley, Thomas J.
    Wen, Patrick
    Schiff, David
    Ligon, Keith
    Haider, Sam
    Karimi, Sasan
    Lassman, Andrew B.
    Nolan, Craig P.
    DeAngelis, Lisa M.
    Gavrilovic, Igor
    Norden, Andrew
    Drappatz, Jan
    Lee, Eudocia Quant
    Purow, Benjamin
    Plotkin, Scott R.
    Batchelor, Tracy
    Abrey, Lauren E.
    Omura, Antonio
    [J]. NEURO-ONCOLOGY, 2015, 17 (01) : 116 - 121
  • [10] Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas
    Kim, Daniel
    Niemierko, Andrzej
    Hwang, William L.
    Stemmer-Rachamimov, Anat O.
    Curry, William T.
    Barker, Fred G., II
    Martuza, Robert L.
    Oh, Kevin S.
    Loeffler, Jay S.
    Shih, Helen A.
    [J]. JOURNAL OF NEUROSURGERY, 2018, 128 (04) : 1123 - 1132